-

Shareholder Alert: Robbins LLP Announces Cheetah Mobile Inc. (CMCM) Sued for Misleading Shareholders

SAN DIEGO & BEIJING--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of Cheetah Mobile Inc. (NYSE: CMCM) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between March 25, 2019 to February 20, 2020. Cheetah Mobile is a mobile Internet company that offers mobile utility, casual games, and live streaming products.

If you suffered a loss as a result of Cheetah Mobile's misconduct, click here.

Cheetah Mobile Inc. (CMCM) Accused of Misleading Shareholders

According to the complaint filed in June 2020, Cheetah Mobile announced positive financial results for its fourth quarter and 2018 annual report. In the following months, Cheetah Mobile continued to issue optimistic financial outlooks. However, the Company failed to disclose that certain Cheetah Mobile apps were in violation of Google's terms of agreement and could lead to the termination the Company's Google advertising contract. On February 21, 2020, Cheetah Mobile revealed that its Google Play Store, Google AdMob, and Google AdManager accounts were disabled on February 20, 2020 "because some of the Company's apps had not been compliant with Google policies, resulting in certain invalid traffic." On this news, the Company's share price fell approximately 17% to close at $2.99 per share on February 21, 2020. On June 10, 2020, Cheetah Mobile announced in its first quarter 2020 financial results that revenues for its mobile utility product business "decreased by 62.6% year over year to RMB54.3 million in first quarter of 2020 . . . mainly due to the suspension of the Company's advertising collaborations with Google." On this news, the Company's share price fell $0.25, or more than 7%, over two consecutive trading sessions to close at $3.10 per share on June 11, 2020, and continues to decline.

If you purchased Cheetah Mobile Inc. (CMCM) securities between March 25, 2019 and February 20, 2020, you have until August 24, 2020, to ask the court to be appointed lead plaintiff for the class.

Contact us to learn more:
Leo Kandinov
(800) 350-6003
lkandinov@robbinsllp.com
Shareholder Information Form

Want to be notified if a class action against CMCM settles? Want to receive free alerts about companies engaged in wrongdoing? Sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:CMCM

Release Versions
$Cashtags

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the uniQure N.V. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired uniQure N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025. uniQure is a biotechnology company developing gene therapies for rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that un...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025. POMDoctor claims to be "a leading online medical services platform for chronic diseases in China." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Alleg...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Inovio Pharmaceuticals, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all persons that purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025. Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papillomavirus (“HPV”). For more information, submit a...
Back to Newsroom